Yu et al. revealed that Lnc-SNHG7 reduces miR-378a-3p and attenuates its control on DVL2, leading to aberrant Wnt/β-catenin activity, which contributes to HSCs activation and liver fibrosis progression [31]. The gene discussed is SNHG7; the disease is Hepatic fibrosis.